| Primary |
| Drug Use For Unknown Indication |
66.7% |
| Osteomyelitis Chronic |
33.3% |
|
| Respiratory Arrest |
50.0% |
| Sensory Loss |
50.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
70.3% |
| Ill-defined Disorder |
15.6% |
| Pain |
6.3% |
| Product Used For Unknown Indication |
6.3% |
| Obsessive-compulsive Disorder |
1.6% |
|
| Completed Suicide |
20.0% |
| Respiratory Arrest |
20.0% |
| Respiratory Depression |
10.0% |
| Cardio-respiratory Arrest |
6.7% |
| Drug Toxicity |
6.7% |
| Cardiac Arrest |
3.3% |
| Medication Error |
3.3% |
| Metabolic Acidosis |
3.3% |
| Narcotic Intoxication |
3.3% |
| Overdose |
3.3% |
| Poisoning Deliberate |
3.3% |
| Self-medication |
3.3% |
| Serotonin Syndrome |
3.3% |
| Somnolence |
3.3% |
| Ventricular Tachycardia |
3.3% |
| Visceral Congestion |
3.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
60.1% |
| Hypertension |
7.0% |
| Depression |
3.4% |
| Premedication |
2.9% |
| Analgesia |
2.8% |
| Prophylaxis |
2.6% |
| Arthritis |
2.1% |
| Hyperhomocysteinaemia |
2.1% |
| Blood Cholesterol Increased |
2.0% |
| Constipation |
1.8% |
| Anticoagulant Therapy |
1.4% |
| Emphysema |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hyperthyroidism |
1.4% |
| Pneumonia |
1.4% |
| Tachycardia |
1.4% |
| Asthma |
1.3% |
| Fibromyalgia |
1.3% |
| Pain |
1.2% |
| Sleep Disorder |
1.2% |
|
| Vomiting |
13.1% |
| Type 2 Diabetes Mellitus |
9.5% |
| Weight Decreased |
8.3% |
| Weight Increased |
8.3% |
| Ventricular Tachycardia |
6.0% |
| Wheezing |
6.0% |
| White Blood Cell Count Decreased |
6.0% |
| Intestinal Obstruction |
4.8% |
| Sepsis |
4.8% |
| Death |
3.6% |
| Incorrect Dose Administered |
3.6% |
| Spinal Fusion Surgery |
3.6% |
| Therapeutic Agent Toxicity |
3.6% |
| Unevaluable Event |
3.6% |
| Visual Field Defect |
3.6% |
| Completed Suicide |
2.4% |
| Diabetes Mellitus |
2.4% |
| Drug Toxicity |
2.4% |
| Dyspnoea |
2.4% |
| Febrile Neutropenia |
2.4% |
|
